60 results
8-K
EX-4.3
JAGX
Jaguar Health Inc
5 Oct 23
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-4.1
JAGX
Jaguar Health Inc
5 Oct 23
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-4.2
JAGX
Jaguar Health Inc
5 Oct 23
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-4.5
JAGX
Jaguar Health Inc
5 Oct 23
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-4.4
JAGX
Jaguar Health Inc
5 Oct 23
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-4.1
xi50k0pc6s6y7l8 ve3
9 May 23
Jaguar Completes Enrollment in its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea
8:30am
8-K
EX-4.1
sirfrm
30 Aug 22
Jaguar Health Secures Additional Capital Through Sale of Royalty Rights Related to Future Crofelemer and Lechlemer Revenue Stream
4:30pm
8-K
EX-4.1
sbmouiid5uf 1l
15 Apr 22
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-4.4
ret0s
15 Apr 22
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-4.3
0m9vp
15 Apr 22
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-4.2
znhca
15 Apr 22
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-4.1
ops20sc3c4w pe
8 Apr 21
Entry into a Material Definitive Agreement
5:21pm
8-K
EX-4.1
xv91 aentzmybcy
11 Mar 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-4.1
4x9k0czal26bu0
22 Jan 21
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-4.1
q7y18 qb6y9
29 Dec 20
Jaguar Health Reports Voting Results from Special Meeting of Stockholders & Announces December 23rd Investor Webinar
5:03pm
8-K
EX-4.1
kk9hi9g
9 Oct 20
Entry into a Material Definitive Agreement
4:40pm
8-K
EX-4.1
hry9e
9 Oct 20
Entry into a Material Definitive Agreement
4:18pm
8-K
EX-4.1
n4off2c9 toxfwe
2 Sep 20
Entry into a Material Definitive Agreement
8:25am
8-K
EX-4.1
86e4ri 0d6
22 May 20
Entry into a Material Definitive Agreement
5:25pm